$20m for Brain Computer Interface using Ultrasound-on-Chip
Butterfly Networks is working with Forest Neurotech on a minimally-invasive device for imaging and stimulating the brain with ultrasound.
The five year co-development agreement includes $20 million to be paid to Butterfly for annual licensing, chip purchases, services and milestone payments, of which $3.5m was received on signing. Additional revenue is anticipated for every unit sold upon commercialization.
Forest will use Butterfly’s ultrasound-on-a-chip technology which can operate at a wide range of frequencies and has programming flexibility for implantable devices. Butterfly has already used the technology for the world’s first handheld, single probe whole-body ultrasound system using semiconductor technology, the Butterfly iQ+.
Forest Neurotech, set up by researchers from Caltech and Google, is developing an ultrasound based brain computer interface (BCI) and software platform to boost both the understanding and personalized treatment of the human brain by measuring and stimulating brain-wide activity in a minimally invasive manner.
“Forest Neurotech is an exemplary partner that validates the vision behind Butterfly Garden. We opened our imaging platform for co-development to encourage and expedite innovation that captures the full potential of Butterfly’s disruptive chip technology through new applications and in adjacent markets. By bringing our chip into the neurotech implantables space, this partnership does exactly that,” said Joseph DeVivo, Butterfly Network’s President, Chief Executive Officer, and Chairman.
The news follows Butterfly’s announcement in August 2023, launching Butterfly Garden to facilitate partnerships with medical device companies, AI companies, or software developers seeking to build new applications with its industry leading imaging platform.
www.butterflynetwork.com/butterfly-garden; www.forestneurotech.org.
If you enjoyed this article, you will like the following ones: don't miss them by subscribing to :
